glp 1 and heart failure Bridging the gap between GLP1-receptor agonists cardiovascular outcomes: evidence for the role of tirzepatide | Cardiovascular Diabetology Effects of GLP-1 Receptor Agonists

not using GLP-1 receptor agonists had significantly lower relative risks for mortality and respiratory failure, according to a presentation at the CHEST Annual Meeting.In a retrospective study, Saud Alawad, MBBS, third-year internal medicine resident at West Virginia University, and colleagues analyzed adults with a group 1 PAH

Overview of GLP-1 Analogue Drugs: Brands, Companies & Clinical Uses GLP-1 analogues have transformed the treatment landscape for Type 2 Diabetes and obesity management offering better glycemic control, cardiovascular benefits, and effective weight loss

Harvard geneticist David Sinclair reveals a rare but serious blindness risk linked to GLP-1 drugs, estimating 20,00030,000 NAION cases per year in

GDF8 GDF8 inhibits fatty acid oxidation in adipose tissue, hinders the formation of brown adipose tissue, and reduces glucose uptake in liver tissue [3]